|
English
|
正體中文
|
简体中文
|
总笔数 :2875232
|
|
造访人次 :
54186053
在线人数 :
1210
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
显示项目 739851-739860 / 2351377 (共235138页)
<< < 73981 73982 73983 73984 73985 73986 73987 73988 73989 73990 > >>
每页显示[10|25|50]项目
| 臺北醫學大學 |
2013 |
Rosiglitazone is Effective to Improve Renal Damage in Type-1-like Diabetic Rats
|
Huang, K-C;Cherng, Y-G;Chen, L-J;Hsu, C-T;Cheng, J-T |
| 臺北醫學大學 |
2013 |
Rosiglitazone is Effective to Improve Renal Damage in Type-1-like Diabetic Rats
|
Huang, K-C;Cherng, Y-G;Chen, L-J;Hsu, C-T;Cheng, J-T |
| 臺北醫學大學 |
2013 |
Rosiglitazone is Effective to Improve Renal Damage in Type-1-like Diabetic Rats
|
Huang, K-C;Cherng, Y-G;Chen, L-J;Hsu, C-T;Cheng, J-T |
| 國家衛生研究院 |
2013-08 |
Rosiglitazone is not associated with an increased risk of bladder cancer
|
Tseng, CH |
| 國立臺灣大學 |
2013 |
Rosiglitazone is not associated with an increased risk of bladder cancer
|
Tseng, Chin-Hsiao; 曾慶孝 |
| 國家衛生研究院 |
2015-02-06 |
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
|
Tseng, CH |
| 臺大學術典藏 |
2015 |
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
|
Tseng, C.-H.; CHIN-HSIAO TSENG |
| 臺大學術典藏 |
2020-06-01T08:33:31Z |
Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese
|
Chin-Hsiao Tseng; CHIN-HSIAO TSENG |
| 國家衛生研究院 |
2013-12 |
Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
|
Tseng, CH |
| 國立臺灣大學 |
2013 |
Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
|
Tseng, Chin-Hsiao; 曾慶孝 |
显示项目 739851-739860 / 2351377 (共235138页)
<< < 73981 73982 73983 73984 73985 73986 73987 73988 73989 73990 > >>
每页显示[10|25|50]项目
|
